Chemopreventive effects of 2-(Allylthio)pyrazine

Archives of Pharmacal Research

Volumn 22, Issue 2, 1999, Pages 99-107

  Kim, Nak Doo ^a   Kim, Sang Geon ^a  

^a Seoul National University   (South Korea)

Author keywords

2 (Allylthio)pyrazine; Chemoprevention; Cytochrome P450; Epoxide hydrolase; Glutathione S transferase; Hepatoprotective Agent; Radioprotection

Indexed keywords

2 (ALLYLTHIO)PYRAZINE; 2-(ALLYLTHIO)PYRAZINE; ANTINEOPLASTIC AGENT; CYTOCHROME P450 2E1; ENZYME INHIBITOR; GLUTATHIONE; PYRAZINE DERIVATIVE; RADIOPROTECTIVE AGENT;

ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; HUMAN; LIVER; METABOLISM; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; CYTOCHROME P-450 CYP2E1; ENZYME INDUCTION; ENZYME INHIBITORS; GLUTATHIONE; HUMANS; LIVER; PYRAZINES; RADIATION-PROTECTIVE AGENTS;

EID: 0033109898     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976531     Document Type: Review

References (65)

1. 1-treated rats. Cancer Res., 41, 650-654 (1981).
2. Boyland, E. and Chasseud, C. F., The role of gluthathione and gluthathione S-transferase in mercapturic acid biosynthesis. Adv. Cancer Res., 29, 175-274 (1979).
3. Brady, J. F., Ishizaki, H., Fukuto, J. M., Lin, M. C., Fadel, A., Gape, J. M. and Yang, C. S., Inibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res. Toxicol., 4, 642-647 (1991).
4. Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R. and Mayer, R. T., Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem. Pharmacol., 48, 923-936 (1994).
5. 1-DNA adduct formed In vivo in rat liver. Proc. Natl. Acad. Sci. USA., 75, 1745-1749 (1978).
6. Eaton, D. L. and Gallagher, E. P., Mechanism of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 34, 135-172 (1994).
7. 1 in vitro. Proc. Natl. Acad Sci. USA., 74, 1870-1874 (1970).
8. 7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ. Health Perspect., 99, 107-113 (1993).
9. 1 induced hepatotoxicity in rats: Inhibition of cytochrome P450 2B and 3A2-mediated bioactivation. Res. Commu. Mol. Pathol. Pharmacol., 102, -78 (1998).
10. 1-induced hepatocarcinogenesis in rats. Chemico-Bio. Interact., in press (1999).
11. 1 and suppression of hepatic ornithine decarboxylase activity by 2-(Allylthio)pyrazine in rats. Mutation Research., in press (1999).
12. Haber, D., Siess, M. -H., Canivenc-Lavier, M. -C., Le Bon, A. M., and Suchetet, M., Differential effects of dietary diallyl sulfide and diallyl sulfide on rat intestinal and hepatic drug-metabolizing enzymes. J. Toxicol. Environ. Hlth., 44, 423-434 (1995).
13. 1- and N-nitrosodiethylamine-induced liver preneoplastic foci in rats fed naturally occurring allyl sulfides. Nutrition and Cancer, 25, 61 -70 (1996).
14. Hayes, J. D. and Pulford, D. J., The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol., 30, 445-600 (1995).
15. Helzlsouer, K. J. and Kensler, T. W., Cancer chemoprotection by oltipraz: experimental and clinical considerations. Pred. Med., 22, 783-795 (1993).
16. 1-S-glutathione in the rat. Xenobiotica, 17, 139-153 (1987).
17. Hong, J. -Y., Wang, T. J., Smith, S., Zhou, S., Pan, J. and Yang, C. S., Inhibitory effects of diallyl sulfide on the metabolism and tumerogenecity of the tobacco-specific carcinogen 4-(methylnitrosoamine)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis, 13, 901-904 (1992).
18. Kelloff, G. J., Boone, C. W., Crowell, J. A., Steele, V. E., Lubet, R. and Sigman, C. C., Chemoprevetive drug development: perspectives and progress. Cancer Epidemiology, Biomarkers & Prevention., 3, 85-98 (1994).
19. Kensler, T. W., Groopman, J. D. and Roebuck, B. D., Chemoprotection by oltipraz and other dithiolethiones. Cancer Chemoprevention, CRC press, Florida., (1992).
20. Kensler, T. W., Groopman, J. D., Eaton, D. L., Curphey, T. J. and Roebuck, B. D., Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis., 13, 95-100 (1992).
21. Kim, S. G., Lee, A. K. and Kim, N. D., Partial hepatoprotective effects of allylthiobenzimidazole in the absence of cytochrome P450 2E1 suppression: Effects on epoxide hydrolase, rGSTA2, rGSTA3/5, rGSTM1 and rGSTM2 expression. Xenobiotica, 28, 323-336 (1998b).
22. Kim, N. D., Kwak, M. K. and Kim, S. G., Inhibition of cytochrome P450 2E1 expression by 2-(allylthio) pyrazine, a potential chemoprotective agent: Hepatoprotective effects. Biochem. Pharmacol., 53, 261-269 (1997b).
23. Kim, S. G., Nam, S. Y., Kim, C. W., Kim, J. H., Cho, C. K. and Yoo, S. Y., Enhancement of radiation-inducible hepatic glutathione S-transferases Ya, Yb 1, Yb2, Yc1, Yc2 gene expression by oltipraz: Possible role in radioprotection. Mol. Pharm., 51, 225-233 (1997a).
24. Kim, S. G., Nam,. S. Y. and Kim, C. W., In vivo radioprotective effects of oltipraz in gamma-irradiated mice. Biochem. Pharmacol., 55, 1585-1590 (1998a).
25. Kim, S. G. and Novak, R. F., The induction of cytochrome P450 2E1 by nitrogen- and sulfur-containing heterocycles: Expression and molecular regulation. Toxicol. Appl. Pharmacol., 120, 257-265 (1993).
26. Kim, N. D., Kim, S. G., and Kwak, M. K., Induction of rat hepatic glutathione S-transferase by allylsulfide, allylmercaptan and allylmethylsulfide and 2-(allylthio) pyrazine. The International Toxicologists (Abstracts of the 7th International Congress of Toxicology, July 2-6, Seattle,WA, U.S.A.) Abstract number, 69-p-8 (1995).
27. Kim, N. D., Kim, S. G. and Kwak, M. K., Enhanced expression of rat microsomal epoxide hydrolase gene by organosulfur compounds. Biochem. Pharmacol., 47, 541-547 (1994).
28. Kim, N. D., Kwak, M. K. and Kim, S. G., Inhibition of cytochrome P450 2E1 expression by 2-(allylthio) pyrazine, a potential chemoprotective agent: Hepatoprotective effects. Biochem. Pharmacol., 53, 261-269 (1997).
29. Kim, S. G., Cho, M. K., Choi, S. H., Kim, H. J., Kwak, M. K. and Kim, N. D., Molecular basis for hepatic detoxifying enzyme induction by 2-(Allylthio)pyrazine in rats in comparison with oltipraz: effects on prooxidant production and DNA degradation. Drug Metab. Dispos., in press, (1999).
30. Kim, S. G., Cho, J. Y., Choi, S. H. and Kim, N. D., Protective effects of 2-(Allylthio)pyrazine on retinoyl palmitate- and pyridine-potentiated carbon tetrachloride-induced hepatotoxicity: Effect on φX-174 DNA strand breakage. Yakhak Hoeji, 40, 727-737 (1996).
31. Kingsnorth, A. N., King, W. W., K., Diekema, K. A., McCann, P. P., Ross, J. S. and Malt, R. A., Inhibition of ornothine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res. 43, 2545.
32. Kojima, T., Tanaka, T., Kawamori, T., Hara, A. and Mori, H., Chemopreventive effects of dietary DL-α-difluromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat, hepatocarcinogenesis. Cancer Res., 53, 3903-3907 (1993).
33. Kwak, M. K., Kim, S. G., Kwak, J. Y., Novak, R. F. and Kim, N. D., Initiation of CYP2E1 expression by organosulfus compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats. Biochem. Pharmacol., 47, 531-539 (1994).
34. Kwak, M. K., Studies on the hepatoprotective effects of 2-(Allylthio)pyrazine, Ph.D. thesis., Seoul National University., (1997).
35. Kwak, M. K., Lee, W. I., Kim, N. D. and Lee, M. G., Metabolic changes of acetaminophen after intravenous administration to rats pretreated with 2-(Allylthio)pyrazine. Biopharm. Drug. Dispos., 19, 273-277 (1998).
36. Langouët, S., Maheo, K., Berthou, F., Morel, F., Lagadic-Gossman, D., Glaise, D., Coles, B., Ketterer, B. and Guillouzo, A., Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. Carcinogenesis., 18, 1343-1349 (1997).
37. Lee, P. J., Jiang, B. H., Chin, B. Y., Iyer, N. V., Alam, J., Semenza, G. L. and Choi, A. M. K., Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem., 272, 5375-5381 (1997).
38. 1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Carcinogenesis, 14, 2423-2425 (1993).
39. McMillan, J. M. and Jollow, D. J., Galactosamine hepatotoxicity: Effect of Galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicol. Appl. Pharmacol., 115, 234-240 (1992).
40. Miller, E. C., some current perspectives on chemical Carcinogenesis in humans and experimental animals: presidential address. Cancer Res., 38, 479-496 (1978).
41. Molders, P. and Jernestron, B., Interaction of glutathione with reactive intermediate. In : A. Larson, S. Orrenius, A. Holgrer, and B. Mannervick (eds). Functions of glutathione : Biochemical, Physiological, Toxicological, and Clinical aspects, Raven Press, N. Y., 99-108 (1983).
42. Morse, M. A. and Stoner, G. D., Cancer chemoprevention: principles and prospects. Carcinogenesis, 14, 1737-1746 (1993).
43. Mulcahy, R. T., Bailey, H. H. and Gipp, J. J., Transfection of complementary DNAs for the heavy and light subunits of human gamma-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan. Cancer Res., 55, 4771-4775 (1995).
44. Nam, S. Y., Kim, J. H., Cho, C. K., Yoo, S. Y. and Kim, S. G., Enhancement of radiation-induced hepatic microsomal epoxide hydrolase gene expression by oltipraz in rats. Radiat. Res., 147, 613-620 (1997).
45. Nam, S. Y., Cho, C. K. and Kim, S. G., Correlation of increased mortality with the suppression of radiation-inducible microsomal epoxide hydrolase and glutathione S transferase gene expression by dexamethasone: Effects on vitamin C and E-induced radioprotection. Biochem. Pharmacol., 56, 1295-1304 (1998).
46. OBrien, T. G., The induction of ornithine decarboxylase as an early, possible obligatory, event in mouse skin carcinogenesis. Cancer Res., 36, 2644-2653 (1976).
47. Oguro, T., Kaneko, E., Numazawa, S., Imaoka, S., Funae, Y. and Yoshida, T., Induction of hepatic heme oxygenase and changes in cytochrome P 450s in response to oxidative stress produced by stilbenes and stilbene oxides in rats. J. Pharmacol. Exp. Ther., 280, 1455-1462 (1997).
48. Pegg, A. E. and McCann, P. P., Polyamine metabolism and function. Am. J. Physiol., 243, C212-C221 (1982).
49. Pinkus, R., Weiner, L. M. and Daniel V., Role of oxidants and antioxidants in the induction of AP-1, NF-κB, and glutathione S-transferase gene expression. J. Biol. Chem., 271, 13422-13429 (1996).
50. Primiano, T., Gastel, J. A., Kensler, T. W. and Sutter, T. R., Isolation of cDNAs representing dithiolethione-responsive genes. Carcinogenesis, 17, 2297-2303 (1996).
51. Primiano, T., Sutter, T. R. and Kensler, T. W. Antioxidant-inducible genes. Advances in Pharmacology., Academic press, Orlando Florida (1997).
52. Rao, C. V., Tokomo, K., Kellof, G. and Reddy, B. S., Inhibition by dietary oltipraz of experimental carcinogenesis induced by azoxymethane in male F 344 rats. Carcinogenesis, 12, 1051-1055 (1991).
53. Rao, C. V., Desai, D., Simi, B., Kulkarni, N., Amin, S. and Reddy, B. S., Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon, Cancer Res., 53, 4182-4188 (1993).
54. Reddy, B. S., Rao, C. V., Rivenson, A., and Kelloff, G., Chemoprevention of colon carcinogenesis by organosulur compounds. Cancer Res., 53, 3493-3498 (1993).
55. Rozhin, J., Wilson, P. S., Bull, A. W. and Nigro, N. D., Ornithine decarboxylase activity in the rat and human colon, Cancer Res., 44, 3226-3230 (1984).
56. Rushmore, T. H., Morton, M. R. and Pickett, C. B., The antioxidant response element: Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem., 266, 11632-11639 (1991).
57. Russel, D. H., Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth. Drug Metab. Rev., 16, 1-88 (1985).
58. Schreck, R., Rieber, P. and Baeuerle, P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO., J., 10, 2247-2258 (1991).
59. Simplicio, P. D., Giannerini, F., Giustarini, D., Lusini, L. and Rossi, R., The role of cysteine in the regulation of blood glutathione-protein mixed disulfides in rats treated with diamide. Toxicol. Appl. Pharmacol., 148, 56-64 (1998).
60. Sparmins, V. L., Barany, G. and Wattenberg, L., Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione-S transferase activity in the mouse. Carcinogenesis, 9, 131-134 (1988).
61. Stipanuk, M. H., Coloso, R. M., Garcia, R. A. G. and Banks., M. F., Cysteine concentration regulates cysteine metabolism to glutathione, sulfate and taurine in rat hepatocytes. J. Nutr., 122, 420-427 (1992).
62. Surh, Y.-J., Lee, R. C.-J., Park, K.-K., Mayne, S. T., Liem, A. and Miller, J. A., Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis, 16, 2467-2471 (1995).
63. Surh, Y. J., Kim, S. G., Park, K. K., Sohn, Y. W., Lee, J. M., Kim, N. D. and Miller, J. A., Chemopreventive effects of 2-(allylthio)pyrazine on hepatic lesion, mutagenesis and tumorigenesis-induced by vinyl carbamate or vinyl carbamate epoxide. Carcinogenesis, 19, 1263-1267 (1998).
64. Wargovich, M. J., Imada, O. and Stephens, L. C., Initiation and post-initiation chemopreventive effects of diallyl sulfide in esophageal carcinogenesis. Cancer Lett., 64, 39-42 (1992).
65. Yao, K. S. and O'dwyer, P. J., Involvement of NF-κB in the induction of NAD(P)H:quinone oxidoreductase (dt-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol., 49, 275-282 (1995).